ALNY vs TWOD · P/E 76, rev $1.29B vs rev $412.0M
Alnylam Pharmaceuticals Inc (ALNY) versus Two Harbors Investment Corp. (TWOD) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Two Harbors Investment Corp. (TWOD) common stock listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported TWOD revenue for 2025-12-31 was $412.0M. Net income was -$454.3M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. TWOD currently screens at market cap $0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. TWOD currently screens at market cap $0.
Not investment advice. Open the ALNY and TWOD stock pages for the full models.
Not investment advice.